Full Text View
Tabular View
No Study Results Posted
Related Studies
Preventing Childhood Antibiotic-Associated Diarrhea by Prebiotics (WGAAD)
This study is ongoing, but not recruiting participants.
Study NCT00826137   Information provided by Soroka University Medical Center
First Received: December 29, 2008   Last Updated: January 20, 2009   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

December 29, 2008
January 20, 2009
December 2008
Prevention of diarrhea. [ Time Frame: During antibiotic treatment+14 days ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00826137 on ClinicalTrials.gov Archive Site
Duration of diarrhea. [ Time Frame: During antibiotic treatment+14 days ] [ Designated as safety issue: No ]
Same as current
 
Preventing Childhood Antibiotic-Associated Diarrhea by Prebiotics
Prebiotics in the Prevention of Antibiotic-Associated Diarrhea in Children

Prospective randomized double-blind study on the effect of prebiotics (inulin and fructo-oligosaccharides) in the prevention of antibiotic-associated diarrhea in children.

Group will get either the product or placebo blindly throughout antibiotic treatment with additional 14 days.

Phase III
Interventional
Prevention, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study
Antibiotic-Associated Diarrhea
  • Dietary Supplement: Inulin and fructo-oligosaccharides.
  • Dietary Supplement: Placebo
  • Experimental: Treated with prebiotics.
  • Placebo Comparator: Placebo treated.
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
200
July 2010
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy children with acute infection.

Exclusion Criteria:

  • Hypersensitivity to antibiotics, chronic illness.
Both
6 Months to 14 Years
No
 
Israel
 
 
NCT00826137
Zvi Weizman, MD, Soroka Medical Center
 
Soroka University Medical Center
 
Principal Investigator: Zvi Weizman, MD Soroka Medical Center
Soroka University Medical Center
January 2009

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.